Taiwanese Biotech Stocks

Lotus Pharmaceutical

Market Cap: NT$76.9b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$60.8b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

TTY Biopharm

Market Cap: NT$20.8b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

ScinoPharm Taiwan

Market Cap: NT$17.1b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, the America, and internationally.

YungShin Global Holding

Market Cap: NT$14.7b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Tanvex BioPharma

Market Cap: NT$12.7b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.8b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

PharmaEngine

Market Cap: NT$9.3b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Acepodia

Market Cap: NT$8.0b

Operates as a clinical stage biotechnology company.

Adimmune

Market Cap: NT$7.6b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Formosa Laboratories

Market Cap: NT$6.8b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

Orient Pharma

Market Cap: NT$6.5b

Engages in the development of new drugs in Taiwan and internationally.

Savior Lifetec

Market Cap: NT$5.9b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.8b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

OBI Pharma

Market Cap: NT$5.8b

A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.

CHO Pharma

Market Cap: NT$5.6b

Engages in research and development of biotechnology in Taiwan.

BioGend Therapeutics

Market Cap: NT$4.6b

Researches, develops, and sells orthopedic medical equipment and related products.

Medigen Biotechnology

Market Cap: NT$4.4b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cell therapy, advanced nucleic acid testing, generic drugs, medical beauty, and vaccine-related products in Taiwan.

Obigen Pharma

Market Cap: NT$4.0b

Engages in research, manufacturing, and promotion of biotechnology and novel botulinum toxin.

Orient EuroPharma

Market Cap: NT$3.8b

A pharmaceutical company, develops and manufactures drugs worldwide.

Nang Kuang Pharmaceutical

Market Cap: NT$3.7b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

BRIM Biotechnology

Market Cap: NT$3.7b

Engages in the research and development of drugs and therapies to combat and cure diseases in Taiwan.

Maxigen Biotech

Market Cap: NT$3.6b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

SunWay Biotech

Market Cap: NT$3.5b

Focuses on professional research and development, and technical material manufacturing and processing business.

Pet Pharm Biotech

Market Cap: NT$3.4b

Manufactures and sells pharmaceutical products.

Syngen BiotechLtd

Market Cap: NT$3.3b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

3D Global Biotech

Market Cap: NT$3.2b

Develops medical materials for human body reconstruction in China.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.2b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Sinew Pharma

Market Cap: NT$2.8b

A biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

HeXun Biosciences

Market Cap: NT$2.7b

Engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.

Synbio Tech

Market Cap: NT$2.7b

Manufactures and sells human healthcare products and probiotics for animals.

Allied Biotech

Market Cap: NT$2.3b

Manufactures and sells carotenoids worldwide.

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.3b

Develops stem cell technology for patients with unmet medical needs.

TSH Biopharm

Market Cap: NT$2.2b

Develops and markets pharmaceutical products in Taiwan.

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$2.1b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Genomics BioSci & Tech.Ltd

Market Cap: NT$1.8b

Operates as a genomic company in Taiwan.